Regarding the distinction between patients with PC and patients with benign prostate hyperplasia, autoantibodies against cyclin B1 were found present in 31.0% of sera from patients with pancreatic cancer while only in 4.8% of patients with benign prostatic hyperplasia (170). The gene discussed is CCNB1; the disease is benign prostatic hyperplasia.